Orthofix Well-Positioned for Sustainable Growth
The company grew in the mid-single digits, driven by its broad product portfolio and increasing U.S. market penetration. Nov 11, 2024
Enovis Builds Momentum After Integration Efforts
The company grew in the mid-single digits on a pro forma basis in the third quarter of 2024 as it shifted back to offense. Nov 08, 2024
Globus Turns In Complete Quarter at Merger 1-Year Mark
The company grew 63% on a reported basis in the third quarter of 2024 as it anniversaried its merger with NuVasive. Nov 07, 2024
Smith+Nephew Structural Improvements Offset by China Headwinds
The company's orthopedic sales grew in the mid-single digits but headwinds in China will have an ongoing impact into 2025. Nov 06, 2024
Orthopedic Companies Report Results from Third Quarter 2024
Stay up to date on the orthopedic market's 3Q performance in 2024 as we update this post with company sales data and industry developments. Nov 06, 2024
Anika Therapeutics Pivots to Leverage HA Expertise
The company declined in the mid-single digits during the third quarter of 2024 as it pivots away from Arthrosurface and Parcus Medical. Nov 05, 2024
ATEC Shifts Gears, Focused on Cash Flow Breakeven
The company grew more than 27% in the third quarter of 2024 as it hones its focus on attaining cash flow breakeven in 2025. Nov 05, 2024
Zimmer Biomet’s ERP Issues Impact 2024 Outlook
The company grew in the mid-single digits in the third quarter of 2024 as it worked through ERP-related issues impacting product availability. Nov 04, 2024
CONMED Adjusts Guidance Due to Hurricane Aftermath
The company's orthopedic sales grew nearly 5% in the third quarter of 2024 but hurricane impacts will impact fourth quarter results. Nov 04, 2024
Stryker Flourishes in Market’s New Normal
The company's orthopedic sales grew in the double digits during the third quarter of 2024 amid robust volume and demand. Nov 01, 2024
